MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Comparative analysis of the quality of life between healthy elderly people and those with Parkinson’s disease

    L. Santos, A. Alonso, N. Luna, J. Greve (São Paulo, Brazil)

    Objective: To compare the impact of PD on the quality of life and functioning of the elderly with and without PD. Background: Parkinson's disease (PD)…
  • MDS Virtual Congress 2020

    KMT2B-related dystonia (DYT28) and Klippel-Feil Syndrome: A new association?

    D. Portela, M. Correa, M. Gomes, G. Noleto, C. Costa, J. Lopes, L. de Oliveira (Teresina, Brazil)

    Objective: To report the association of lysine-specific histone-methyltransferase 2B gene (KMT2B)-related dystonia (DYT28) and Klippel-Feil Syndrome (KFS). Background: Dystonia is a hyperkinetic movement disorder characterized…
  • MDS Virtual Congress 2020

    Feasibility of video-based motion analysis to rate the severity of tremor and bradykinesia in Parkinson’s disease

    K.W Park, S.Y Jo, E.J Lee, D.W Kang, J.G Lee, J.S Lee, J.H Chung, S.J Chung (Seoul, Republic of Korea)

    Objective: To evaluate the feasibility of video-based motion analysis for rating resting tremor and finger tapping in Parkinson’s disease. Background: Unified Parkinson’s Disease Rating Scale…
  • MDS Virtual Congress 2020

    Identification of Factors that Impact Adherence to OnabotulinumtoxinA Treatment for Spasticity in Post-Stroke and Multiple Sclerosis Patients from ASPIRE

    A. Esquenazi, W. Feng, G. Wittenberg, P. Gallien, A. Baricich, K. Fanning, A. Zuzek, G. Francisco, D. Bandari (Elkins Park, PA, USA)

    Objective: Identify baseline clinical characteristics and treatment-related factors that impact adherence to onabotulinumtoxinA (onabotA) treatment in post-stroke and multiple sclerosis (MS) patients from the Adult…
  • MDS Virtual Congress 2020

    Non-Staged Bilateral GPi DBS Lead Revision Using iMRI: A Case Report

    B. Hwang, D. Mampre, K. Mills, A. Butala, W. Anderson (Baltimore, MD, USA)

    Objective: To demonstrate the feasibility of non-staged intraoperative MRI (iMRI) deep brain stimulation (DBS) lead revision under general anesthesia (GA). Background: DBS lead revision surgery…
  • MDS Virtual Congress 2020

    Treatment of medically refractory orthostatic tremor: deep brain stimulation of bilateral thalamic ventral intermediate nucleus with sustained symptomatic improvement

    D. Sugar, M. Zorn, C. Aquino, J. Rolston, P. Moretti (Salt Lake City, UT, USA)

    Objective: We describe a case of medically refractory orthostatic tremor successfully treated with deep brain stimulation in the ventral intermediate nucleus (Vim) of the thalamus.…
  • MDS Virtual Congress 2020

    First Case of Tongue Twisting During Screening of STN DBS for Parkinson’s Disease: A Unique form of Pyramidal Tract Activation

    Y. Degirmenci, H. Akram, V. Dayal, L. Zrinzo, M. Hariz, P. Lİmousin (Duzce, Turkey)

    Objective: STN-DBS is an effective,generally well-tolerated therapy in selected patients experiencing motor fluctuations,dyskinesia,resistant tremor despite oral/transdermal treatment. Side-effects can occur due to spread of electrical…
  • MDS Virtual Congress 2020

    Directional programming in GPi-DBS for Parkinson’s disease and retrospective assessment of UPDRS III outcomes: First clinical case series

    H. Leal Bailey, J. Donnelly, S. Pallavaram, J. Ramirez Castaneda (San Antonio, TX, USA)

    Objective: To describe our methodology for directional programming in GPi-DBS for PD and report on retrospective assessment of stable programming settings, energy savings using specific…
  • MDS Virtual Congress 2020

    PF-QII Analysis of Deep Brain Stimulation versus Levodopa-carbidopa Intestinal Gel: Real-world Differences in Patient Characteristics and Quality of Life Outcomes

    N. Shetty, C. Zadikoff, S. Wu, Y. Wu, T. Simuni (Chicago, IL, USA)

    Objective: To evaluate differences in demographics, disease characteristics, quality of life (QOL), and caregiver burden (CB) between deep brain stimulation (DBS) and levodopa-carbidopa intestinal gel…
  • MDS Virtual Congress 2020

    Voltage Adjustment Effects More on Limb Symptoms than Axial Symptoms in Parkinson’s Disease Patients Treated with Subthalamic Nucleus Stimulation

    W. Xian, L. Chen, J. Liu, C. Yang (Guangzhou, China)

    Objective: To assess the impact of different parameters (voltage, pulse width, frequency) of subthalamic nucleus (STN) deep brain stimulation (DBS) on axial and limb symptoms…
  • « Previous Page
  • 1
  • …
  • 81
  • 82
  • 83
  • 84
  • 85
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Movement disorders in chronic obstructive pulmonary disease (COPD); the effect of pulmonary disease to brain
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley